Bayer is nearing the end of the road for glyphosate, executives say

Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.

Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.

More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.

Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.

Related Stories
High Path Avian Influenza has significantly impacted poultry and egg prices recently. Will consumers face the same pressures this Thanksgiving?
Let’s meet Rylee Smith from the Oolaga FFA chapter in Oklahoma, one of this year’s Star finalists in agriscience placement.
Let’s meet Wylie Schwebach from the Moriarty FFA chapter in New Mexico, one of this year’s Star finalists in agricultural placement.
National FFA Secretary Grant Northfleet shares his motivation behind a year of service, highlighting the organization’s role in providing students with real success through hard work.

LATEST STORIES BY THIS AUTHOR:

RFD-TV News contributor Roger McOwen covers important topics in ag law and taxation, including FBAR, Read Before Signing, Reporting 4-H Income, and Attorney-Client Privilege.
A five-year-old in Etheridge, Tennessee, lost his life in a grain auger. His mother shares her story to ensure that other farm families do not have to endure that pain. RFD-TV’s own Tammi Arender reports.